Abstract
Lithium is a widely used and effective treatment for mood disorders. In the short term, patients may experience transitory gastrointestinal (GI) side effects or mild tremor, whilst a proportion of patients develop a reversible nephrogenic diabetes insipidus. Endocrine disorders—goitre, hypothyroidism, hyperthyroidism, hyperparathyroidism and weight gain—may occur in the long term. Exacerbation or development of skin and hair conditions due to lithium therapy has been reported in the literature, but good quality evidence is still needed to verify this association. Regular monitoring whilst taking lithium is essential to identify patients at risk of developing adverse effects and to provide safe and effective treatment.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ahmadi-Abhari SA, Ghaeli P, Fahimi F, Esfahanian F, Farsam H, Dehpour AR, Jahanzad I, Hatmi ZN, Dashti S (2003) Risk factors of thyroid abnormalities in bipolar patients receiving lithium: a case control study. BMC Psychiatry 3:4
Atmaca M, Kuloglu M, Tezcan E, Ustundag B (2002) Weight gain and serum leptin levels in patients on lithium treatment. Neuropsychobiology 46(2):67–69
Baptista T, Lacruz A, De Mendoza S, Guillen MM, Burguera JL, De Burguera M, Hernandez L (2000) Endocrine effects of lithium carbonate in healthy premenopausal women: relationship with body weight regulation. Prog Neuropsychopharmacol Biol Psychiatry 24(1):1–16. doi:10.1016/s0278-5846(99)00085-8
Bauer M, Blumentritt H, Finke R, Schlattmann P, Adli M, Baethge C, Bschor T, Mueller-Oerlinghausen B, Berghoefer A (2007) Using ultrasonography to determine thyroid size and prevalence of goiter in lithium-treated patients with affective disorders. J Affect Disord 104(1–3):45–51. doi:10.1016/j.jad.2007.01.033
Bedford JJ, Weggery S, Ellis G, McDonald FJ, Joyce PR, Leader JP, Walker RJ (2008) Lithium-induced nephrogenic diabetes insipidus: renal effects of amiloride. Clin J Am Soc Nephrol 3(5):1324–1331. doi:10.2215/cjn.01640408
Bendz H (2003) Renal and parathyroid function in psychiatric patients on lithium treatment. Nord J Psychiatry 57(1):68–69
Berens SC, Wolff J, Murphy DL (1970) Lithium concentration by thyroid. Endocrinology 87(5):1085
Bjoro THJ, Krüger O, Midthjell K, Hunstad K, Schreiner T, Sandnes L, Brochmann H (2000) Prevalence of thyroid disease, thyroid dysfunction and thyroid peroxidase antibodies in a large, unselected population. The Health Study of Nord-Trondelag (HUNT). Eur J Endocrinol 143(5):639–647
Blount MA, Sim JH, Zhou R, Martin CF, Lu W, Sands JM, Klein JD (2010) Expression of transporters involved in urine concentration recovers differently after cessation of lithium treatment. Am J Physiol Ren Physiol 298(3):F601–F608. doi:10.1152/ajprenal.00424.2009
Bocchetta A, Loviselli A (2006) Lithium treatment and thyroid abnormalities. Clin Pract Epidemiol Ment Health 2:23
Bocchetta A, Bernardi F, Pedditzi M, Loviselli A, Velluzzi F, Martino E, DelZompo M (1991) Thyroid abnormalities during lithium treatment. Acta Psychiatr Scand 83(3):193–198
Bocchetta A, Cherchi A, Loviselli A, Mossa P, Velluzzi F, Derai R, DelZompo M (1996) Six-year follow-up of thyroid function during lithium treatment. Acta Psychiatr Scand 94(1):45–48
Bocchetta A, Cocco F, Velluzzi F, Del Zompo M, Mariotti S, Loviselli A (2007) Fifteen-year follow-up of thyroid function in lithium patients. J Endocrinol Invest 30(5):363–366
Boelaert KFJ (2005) Thyroid hormone in health and disease. J Endocrinol 187(1):1–15
Bopp JM, Miklowitz DJ, Goodwin GM, Stevens W, Rendell JM, Geddes JR (2010) The longitudinal course of bipolar disorder as revealed through weekly text messaging: a feasibility study. Bipolar Disord 12(3):327–334. doi:10.1111/j.1399-5618.2010.00807.x
Bowden CL, Calabrese JR, McElroy SL, Gyulai L, Wassef A, Petty F, Pope HG, Chou JCY, Keck PE, Rhodes LJ, Swann AC, Hirschfeld RMA, Wozniak PJ, Divalproex Maintenance SG (2000) A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder. Arch Gen Psychiatry 57(5):481–489
Brauchli YB, Jick SS, Curtin F, Meier CR (2009) Lithium, antipsychotics, and risk of psoriasis. J Clin Psychopharmacol 29(2):134–140. doi:10.1097/JCP.0b013e31819a4b7c
Burrow GN, Burke WR, Himmelho JM, Spencer RP, Hershman JM (1971) Effect of lithium on thyroid function. J Clin Endocrinol Metab 32(5):647
Calabrese JR, Shelton MD, Rapport DJ, Youngstrom EA, Jackson K, Bilali S, Ganocy SJ, Findling RL (2005) A 20-month, double-blind, maintenance trial of lithium versus divalproex in rapid-cycling bipolar disorder. Am J Psychiatr 162(11):2152–2161
Chakrabarti S (2011) Thyroid functions and bipolar affective disorder. J Thyroid Res 2011:306367. doi:10.4061/2011/306367
Dols A, Sienaert P, van Gerven H, Schouws S, Stevens A, Kupka R, Stek ML (2013) The prevalence and management of side effects of lithium and anticonvulsants as mood stabilizers in bipolar disorder from a clinical perspective: a review. Int Clin Psychopharmacol 28(6):287–296
Duncavage MB, Nasr SJ, Altman EG (1983) Subjective side-effects of lithium-carbonate – a longitudinal-study. J Clin Psychopharmacol 3(2):100–102
Elmslie JL, Mann JI, Silverstone JT, Williams SM, Romans SE (2001) Determinants of overweight and obesity in patients with bipolar disorder. J Clin Psychiatry 62(6):486–491
Haggerty JJ, Prange AJ (1995) Borderline hypothyroidism and depression. Annu Rev Med 46:37–46. doi:10.1146/annurev.med.46.1.37
Himmerich H, Koethe D, Schuld A, Yassouridis A, Pollmacher T (2005) Plasma levels of leptin and endogenous immune modulators during treatment with carbamazepine or lithium. Psychopharmacology (Berl) 179(2):447–451. doi:10.1007/s00213-004-2038-9
Hundley JC, Woodrum DT, Saunders BD, Doherty GM, Gauger PG (2005) Revisiting lithium-associated hyperparathyroidism in the era of intraoperative parathyroid hormone monitoring. Surgery 138(6):1027–1031. doi:10.1016/.j.surg.2005.09.028
Jafferany M (2008) Lithium and psoriasis: what primary care and family physicians should know. Prim Care Companion J Clin Psychiatry 10(6):435–439
Kalita P, Bahn A, Bedford J, Leader J, Walker R (2013) Long-term modulation of lithium-induced nephrogenic diabetes insipidus by amiloride. Nephrology 18:37–37
Khandelwal D, Tandon N (2012) Overt and subclinical hypothyroidism: who to treat and how. Drugs 72(1):17–33. doi:10.2165/11598070-000000000-00000
Kibirige D, Luzinda K, Ssekitoleko R (2013) Spectrum of lithium induced thyroid abnormalities: a current perspective. Thyroid Res 6(1):3–3. doi:10.1186/1756-6614-6-3
Kim B, Kim S, McIntyre RS, Park HJ, Kim SY, Joo YH (2009) Correlates of metabolic abnormalities in bipolar I disorder at initiation of acute phase treatment. Psychiatry Invest 6(2):78–84
Kotwal R, Guerdjikova A, McElroy SL, Keck PE Jr (2006) Lithium augmentation of topiramate for bipolar disorder with comorbid binge eating disorder and obesity. Hum Psychopharmacol Clin Exp 21(7):425–431. doi:10.1002/hup.783
Lazarus JH (1998) The effects of lithium therapy on thyroid and thyrotropin-releasing hormone. Thyroid 8(10):909–913. doi:10.1089/thy.1998.8.909
Lydiard RB, Gelenberg AJ (1982) Hazards and adverse-effects of lithium. Annu Rev Med 33:327–344. doi:10.1146/annurev.me.33.020182.001551
Mahmoudi-Gharaei J, Shahrivar Z, Faghihi T, Mohammadi MR, Tehrani-Doost M, Alaghband-Rad J, Ghaeli P (2012) Topiramate versus valproate sodium as adjunctive therapies to a combination of lithium and risperidone for adolescents with bipolar I disorder: effects on weight and serum lipid profiles. Iran J Psychiatry 7(1):1–10
McKnight RF, Adida M, Budge K, Stockton S, Goodwin GM, Geddes JR (2012) Lithium toxicity profile: a systematic review and meta-analysis. Lancet 379(9817):721–728. doi:10.1016/s0140-6736(11)61516-x
Miller KK, Daniels GH (2001) Association between lithium use and thyrotoxicosis caused by silent thyroiditis. Clin Endocrinol (Oxf) 55(4):501–508
Netto IPR (2014) Lithium prescribing trends: review. Int J Healthc Biomed Res 2(2):95–103
NICE (2014) Bipolar disorder: Assessment and management. CG185. https://www.nice.org.uk/guidance/cg185
Ozbulut O, Guler O, Kurt E, Alatas G, Serteser M, Gecici O (2007) Effects of lithium treatment on ghrelin, leptin and cholesterol levels in patients with euthymic bipolar disorder. Neurol Psychiatry Brain Res 14(3):127–130
Ozpoyraz N, Tamam L, Kulan E, Sert M (2002) Thyroid functions in lithium-treated patients. Eur Neuropsychopharmacol 12:S435–S435
Ozsoy S, Mavili E, Aydin M, Turan T, Esel E (2010) Ultrasonically determined thyroid volume and thyroid functions in lithium-naive and lithium-treated patients with bipolar disorder: a cross-sectional and longitudinal study. Hum Psychopharmacol Clin Exp 25(2):174–178
Perrild H, Hegedus L, Baastrup PC, Kayser L, Kastberg S (1990) Thyroid-function and ultrasonically determined thyroid size in patients receiving long-term lithium treatment. Am J Psychiatr 147(11):1518–1521
Persson G (1977) Lithium side effects in relation to dose and to levels and gradients of lithium in plasma. Acta Psychiatr Scand 55(3):208–213. doi:10.1111/j.1600-0447.1977.tb00163.x
Pham CBSA (2008) Should we treat subclinical hypothyroidism? BMJ 337:a834
Rosser R (1976) Thyrotoxicosis and lithium. Br J Psychiatry 128:61–66
Schou M, Amdisen A, Jensen SE, Olsen T (1968) Occurrence of goitre during lithium treatment. Br Med J 3(5620):710
Shine B, Mcknight R, Leaver L, Geddes J (2015) Long-term effects of lithium on renal, thyroid, and parathyroid function: a retrospective analysis of laboratory data. The Lancet 386(9992):461–468
Souza FGM, Mander AJ, Foggo M, Dick H, Shearing CH, Goodwin GM (1991) The effects of lithium discontinuation and the non-effect of oral inositol upon thyroid-hormones and cortisol in patients with bipolar affective-disorder. J Affect Disord 22(3):165–170. doi:10.1016/0165-0327(91)90050-3
Taylor DPC, Kapur S (2012) Prescribing guidelines in psychiatry, 11th edn. Wiley-Blackwell, London
Vanina Y, Podolskaya A, Sedky K, Shahab H, Siddiqui A, Munshi F, Lippmann S (2002) Body weight changes associated with psychopharmacology. Psychiatr Serv 53(7):842–847. doi:10.1176/appi.ps.53.7.842
Vestergaard P, Amdisen A, Schou M (1980) Clinically significant side effects of lithium treatment a survey of 237 patients in long-term treatment. Acta Psychiatr Scand 62(3):193–200. doi:10.1111/j.1600-0447.1980.tb00607.x
Vieweg WVR, Godleski LS, Hundley PL, Yank GR (1988) Lithium, polyuria and abnormal diurnal weight-gain in psychosis. Acta Psychiatr Scand 78(4):510–514. doi:10.1111/j.1600-0447.1988.tb06375.x
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing Switzerland
About this chapter
Cite this chapter
McKnight, R.F., Geddes, J.R., Goodwin, G.M. (2017). Short- and Midterm Side Effects of Lithium Therapy. In: Malhi, G., Masson, M., Bellivier, F. (eds) The Science and Practice of Lithium Therapy. Springer, Cham. https://doi.org/10.1007/978-3-319-45923-3_15
Download citation
DOI: https://doi.org/10.1007/978-3-319-45923-3_15
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-45921-9
Online ISBN: 978-3-319-45923-3
eBook Packages: MedicineMedicine (R0)